Ventana discovers, develops, and delivers medical diagnostic systems and biopsy-based cancer tests. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 200 cancer tests for the four million people afflicted with cancer annually. Ventana completed an IPO in 1995 and was acquired by The Roche Group in 2008. The company still operates under the Ventana name.